A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
ROLE OF DIABETES AND NONALCOHOLIC FATTY LIVER DISEASE FOR HCC DEVELOPMENT
2022
EXPERIMENTAL & CLINICAL MEDICINE GEORGIA
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is a leading cause of cancer-related death worldwide. Despite advances in prevention techniques, screening, and new technologies in both diagnosis and treatment, incidence and mortality continue to rise. Cirrhosis remains the most important risk factor for the development of HCC regardless of etiology. Chronic medical conditions such as diabetes mellitus and obesity increase the risk of HCC. Diabetes mellitus
doi:10.52340/jecm.2022.717
fatcat:whlopb3vqbftleqpd3skcbpdli